About Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
Instituto do Câncer de São Paulo Octavio Frias de Oliveira é um centro de atendimento médico e hospitalar que funciona como autarquia vinculada ao Governo do Estado de São Paulo.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
During the past decade, Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa"
#1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
According to Clinical.Site data, the most researched conditions in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa" are
"Metastatic Colorectal Cancer" (2 trials). Many other conditions were trialed in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa" in a lesser frequency.
Clinical Trials Intervention Types at Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
Most popular intervention types in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Capecitabine + bevacizumab" (1 trials), "Trifluridine/Tipiracil hydrochloride (S95005)" (1 trials) and "Trifluridine/tipiracil + bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
The vast majority of trials in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa" are
2 trials for "All" genders.
Clinical Trials Status at Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
Currently, there are NaN active trials in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".